Prominin-1 (CD133) is a cholesterol-binding membrane glycoprotein selectively associated with highly curved and prominent membrane structures. It is widely recognized as an antigenic marker of stem cells and cancer stem cells and is frequently used to isolate them from biological and clinical samples. Recent progress in understanding various aspects of CD133 biology in different cell types has revealed the involvement of CD133 in the architecture and dynamics of plasma membrane protrusions, such as microvilli and cilia, including the release of extracellular vesicles, as well as in various signaling pathways, which may be regulated in part by posttranslational modifications of CD133 and its interactions with a variety of proteins and lipids. Hence, CD133 appears to be a master regulator of cell signaling as its engagement in PI3K/Akt, Src-FAK, Wnt/β-catenin, TGF-β/Smad and MAPK/ERK pathways may explain its broad action in many cellular processes, including cell proliferation, differentiation, and migration or intercellular communication. Here, we summarize early studies on CD133, as they are essential to grasp its novel features, and describe recent evidence demonstrating that this unique molecule is involved in membrane dynamics and molecular signaling that affects various facets of tissue homeostasis and cancer development. We hope this review will provide an informative resource for future efforts to elucidate the details of CD133's molecular function in health and disease.

Biotechnology Center Technische Universität Dresden Tatzberg 47 49 01307 Dresden Germany

International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Laboratory of Tumor Biology Department of Experimental Biology Faculty of Science Masaryk University Kamenice 5 625 00 Brno Czech Republic

Tissue Engineering Laboratories Medizinische Fakultät der Technischen Universität Dresden Dresden Germany

Zobrazit více v PubMed

Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A. 1997;94:12425–12430. doi: 10.1073/pnas.94.23.12425. PubMed DOI PMC

Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90:5002–5012. doi: 10.1182/blood.V90.12.5002. PubMed DOI

Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997;90:5013–5021. doi: 10.1182/blood.V90.12.5013. PubMed DOI

Horn PA, Tesch H, Staib P, Schoch C, Kube D, Diehl V, et al. Significance of AC133 and CD34 expression on acute myeloid leukemia cells. In: Büchner T, Hiddemann W, Wörmann B, Schellong G, Ritter J, Creutzig U, et al., editors. Acute Leukemias VIII: Prognostic Factors and Treatment Strategies. Berlin Heidelberg: Springer; 2001. pp. 160–5.

Bühring HJ, Seiffert M, Marxer A, Weiss B, Faul C, Kanz L, Brugger W. AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood. 1999;94:832–3. doi: 10.1182/blood.V94.2.832. PubMed DOI

Bühring HJ, Seiffert M, Bock TA, Scheding S, Thiel A, Scheffold A, et al. Expression of novel surface antigens on early hematopoietic cells. Ann N Y Acad Sci. 1999;872:25–39. doi: 10.1111/j.1749-6632.1999.tb08450.x. PubMed DOI

Corbeil D, Röper K, Hellwig A, Tavian M, Miraglia S, Watt SM, et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem. 2000;275:5512–5520. doi: 10.1074/jbc.275.8.5512. PubMed DOI

Maw MA, Corbeil D, Koch J, Hellwig A, Wilson-Wheeler JC, Bridges RJ, et al. A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet. 2000;9:27–34. doi: 10.1093/hmg/9.1.27. PubMed DOI

Corbeil D, Fargeas CA, Huttner WB. Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein. Biochem Biophys Res Commun. 2001;285:939–944. doi: 10.1006/bbrc.2001.5271. PubMed DOI

Fargeas CA, Joester A, Missol-Kolka E, Hellwig A, Huttner WB, Corbeil D. Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci. 2004;117:4301–4311. doi: 10.1242/jcs.01315. PubMed DOI

Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 2005;319:15–26. doi: 10.1007/s00441-004-1018-z. PubMed DOI

Jászai J, Farkas LM, Fargeas CA, Janich P, Haase M, Huttner WB, et al. Prominin-2 is a novel marker of distal tubules and collecting ducts of the human and murine kidney. Histochem Cell Biol. 2010;133:527–539. doi: 10.1007/s00418-010-0690-1. PubMed DOI

Gashaw I, Dushaj O, Behr R, Biermann K, Brehm R, Rubben H, et al. Novel germ cell markers characterize testicular seminoma and fetal testis. Mol Hum Reprod. 2007;13:721–727. doi: 10.1093/molehr/gam059. PubMed DOI

Pereira MF, Fernandes SA, Nascimento AR, Siu ER, Hess RA, Oliveira CA, et al. Effects of the oestrogen receptor antagonist Fulvestrant on expression of genes that affect organization of the epididymal epithelium. Andrology. 2014;2:559–571. doi: 10.1111/j.2047-2927.2014.00219.x. PubMed DOI

Jászai J, Janich P, Farkas LM, Fargeas CA, Huttner WB, Corbeil D. Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice. Histochem Cell Biol. 2007;128:409–419. doi: 10.1007/s00418-007-0334-2. PubMed DOI

Immervoll H, Hoem D, Sakariassen PØ, Steffensen OJ, Molven A. Expression of the “stem cell marker” CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer. 2008;8:48. doi: 10.1186/1471-2407-8-48. PubMed DOI PMC

Karbanová J, Missol-Kolka E, Fonseca A-V, Lorra C, Janich P, Hollerová H, et al. The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem. 2008;56:977–993. doi: 10.1369/jhc.2008.951897. PubMed DOI PMC

Anderson LH, Boulanger CA, Smith GH, Carmeliet P, Watson CJ. Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev Dyn. 2011;240:674–681. doi: 10.1002/dvdy.22539. PubMed DOI PMC

Suzuki A, Sekiya S, Onishi M, Oshima N, Kiyonari H, Nakauchi H, et al. Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology. 2008;48:1964–1978. doi: 10.1002/hep.22558. PubMed DOI

Lee H, Yu DM, Park JS, Lee H, Kim JS, Kim HL, et al. Prominin-1-Radixin axis controls hepatic gluconeogenesis by regulating PKA activity. EMBO Rep. 2020;21:e49416. doi: 10.15252/embr.201949416. PubMed DOI PMC

Lardon J, Corbeil D, Huttner WB, Ling Z, Bouwens L. Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas. 2008;36:e1–6. doi: 10.1097/mpa.0b013e318149f2dc. PubMed DOI

Corbeil D, Röper K, Fargeas CA, Joester A, Huttner WB. Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic. 2001;2:82–91. doi: 10.1034/j.1600-0854.2001.020202.x. PubMed DOI

Zacchigna S, Oh H, Wilsch-Bräuninger M, Missol-Kolka E, Jászai J, Jansen S, et al. Loss of the cholesterol-binding protein prominin-1/CD133 causes disk dysmorphogenesis and photoreceptor degeneration. J Neurosci. 2009;29:2297–2308. doi: 10.1523/JNEUROSCI.2034-08.2009. PubMed DOI PMC

Karbanová J, Laco J, Marzesco A-M, Janich P, Voborníková M, Mokrý J, et al. Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form. PLoS ONE. 2014;9:e98927. doi: 10.1371/journal.pone.0098927. PubMed DOI PMC

Jászai J, Fargeas CA, Graupner S, Tanaka EM, Brand M, Huttner WB, et al. Distinct and conserved prominin-1/CD133–positive retinal cell populations identified across species. PLoS ONE. 2011;6:e17590. doi: 10.1371/journal.pone.0017590. PubMed DOI PMC

Corbeil D, Joester A, Fargeas CA, Jászai J, Garwood J, Hellwig A, et al. Expression of distinct splice variants of the stem cell marker prominin-1 (CD133) in glial cells. Glia. 2009;57:860–874. doi: 10.1002/glia.20812. PubMed DOI

Fargeas CA, Fonseca A-V, Huttner WB, Corbeil D. Prominin-1 (CD133): from progenitor cells to human diseases. Future Lipidol. 2006;1:213–225. doi: 10.2217/17460875.1.2.213. DOI

Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821–5828. PubMed

Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401. doi: 10.1038/nature03128. PubMed DOI

Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003;100:15178–15183. doi: 10.1073/pnas.2036535100. PubMed DOI PMC

Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res. 2008;14:123–129. doi: 10.1158/1078-0432.CCR-07-0932. PubMed DOI

Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z, et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res. 2008;27:85. doi: 10.1186/1756-9966-27-85. PubMed DOI PMC

Liou GY. CD133 as a regulator of cancer metastasis through the cancer stem cells. Int J Biochem Cell Biol. 2019;106:1–7. doi: 10.1016/j.biocel.2018.10.013. PubMed DOI PMC

Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. 2013;229:355–378. doi: 10.1002/path.4086. PubMed DOI

Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000;97:14720–14725. doi: 10.1073/pnas.97.26.14720. PubMed DOI PMC

Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, et al. Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci. 2005;8:723–729. doi: 10.1038/nn1473. PubMed DOI PMC

Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67:4010–4015. doi: 10.1158/0008-5472.CAN-06-4180. PubMed DOI

Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci. 2004;117:3539–3545. doi: 10.1242/jcs.01222. PubMed DOI

Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT–immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 2007;67:3153–3161. doi: 10.1158/0008-5472.CAN-06-4429. PubMed DOI

Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, Demarzo AM, Isaacs JT. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res. 2008;68:9703–9711. doi: 10.1158/0008-5472.CAN-08-3084. PubMed DOI PMC

Missol-Kolka E, Karbanová J, Janich P, Haase M, Fargeas CA, Huttner WB, et al. Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate. 2011;71:254–267. doi: 10.1002/pros.21239. PubMed DOI

Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005;65:10946–10951. doi: 10.1158/0008-5472.CAN-05-2018. PubMed DOI

Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 2005;166:545–555. doi: 10.1016/S0002-9440(10)62276-6. PubMed DOI PMC

Angelotti ML, Ronconi E, Ballerini L, Peired A, Mazzinghi B, Sagrinati C, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells. 2012;30:1714–1725. doi: 10.1002/stem.1130. PubMed DOI

Sagrinati C, Netti GS, Mazzinghi B, Lazzeri E, Liotta F, Frosali F, et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol. 2006;17:2443–2456. doi: 10.1681/ASN.2006010089. PubMed DOI

Lindgren D, Boström AK, Nilsson K, Hansson J, Sjölund J, Möller C, et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol. 2011;178:828–837. doi: 10.1016/j.ajpath.2010.10.026. PubMed DOI PMC

Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006;351:820–824. doi: 10.1016/j.bbrc.2006.10.128. PubMed DOI

Kordes C, Sawitza I, Müller-Marbach A, Ale-Agha N, Keitel V, Klonowski-Stumpe H, et al. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun. 2007;352:410–417. doi: 10.1016/j.bbrc.2006.11.029. PubMed DOI

Dorrell C, Erker L, Schug J, Kopp JL, Canaday PS, Fox AJ, et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev. 2011;25:1193–1203. doi: 10.1101/gad.2029411. PubMed DOI PMC

Oshima Y, Suzuki A, Kawashimo K, Ishikawa M, Ohkohchi N, Taniguchi H. Isolation of mouse pancreatic ductal progenitor cells expressing CD133 and c-Met by flow cytometric cell sorting. Gastroenterology. 2007;132:720–732. doi: 10.1053/j.gastro.2006.11.027. PubMed DOI

Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313–323. doi: 10.1016/j.stem.2007.06.002. PubMed DOI

O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106–110. doi: 10.1038/nature05372. PubMed DOI

Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111–115. doi: 10.1038/nature05384. PubMed DOI

Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature. 2009;457:603–607. doi: 10.1038/nature07589. PubMed DOI PMC

Snippert HJ, van Es JH, van den Born M, Begthel H, Stange DE, Barker N, et al. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology. 2009;136:2187–2194.e2181. doi: 10.1053/j.gastro.2009.03.002. PubMed DOI

Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15:504–514. doi: 10.1038/sj.cdd.4402283. PubMed DOI

Monzani E, Facchetti F, Galmozzi E, Corsini E, Benetti A, Cavazzin C, et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer. 2007;43:935–946. doi: 10.1016/j.ejca.2007.01.017. PubMed DOI

Ito Y, Hamazaki TS, Ohnuma K, Tamaki K, Asashima M, Okochi H. Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol. 2007;127:1052–1060. doi: 10.1038/sj.jid.5700665. PubMed DOI

Kratz-Albers K, Zühlsdorp M, Leo R, Berdel WL, Büchner T, Serve H. Expression of a AC133, a novel stem cell marker, on human leukemic blasts lacking CD34-antigen and on a human CD34+ leukemic line:MUTZ-2. Blood. 1998;92:4485–4487. doi: 10.1182/blood.V92.11.4485. PubMed DOI

Horn PA, Tesch H, Staib P, Kube D, Diehl V, Voliotis D. Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood. 1999;93:1435–1437. doi: 10.1182/blood.V93.4.1435. PubMed DOI

Wuchter C, Ratei R, Spahn G, Schoch, C, Harbott J, Schnittger, S et al. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. Haematologica. 2001;86:154-61. PubMed

Cox CV, Diamanti P, Evely RS, Kearns PR, Blair A. Expression of CD133 on leukemia-initiating cells in childhood ALL. Blood. 2009;113:3287–3296. doi: 10.1182/blood-2008-04-154187. PubMed DOI

Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–958. doi: 10.1182/blood.V95.3.952.003k27_952_958. PubMed DOI

Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000;95:3106–3112. doi: 10.1182/blood.V95.10.3106. PubMed DOI

Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G, et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol. 2004;57:965–969. doi: 10.1136/jcp.2004.016444. PubMed DOI PMC

Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001;115:186–194. doi: 10.1046/j.1365-2141.2001.03077.x. PubMed DOI

Sekine A, Nishiwaki T, Nishimura R, Kawasaki T, Urushibara T, Suda R, et al. Prominin-1/CD133 expression as potential tissue-resident vascular endothelial progenitor cells in the pulmonary circulation. Am J Physiol Lung Cell Mol Physiol. 2016;310:L1130–1142. doi: 10.1152/ajplung.00375.2014. PubMed DOI

Rossi E, Poirault-Chassac S, Bieche I, Chocron R, Schnitzler A, Lokajczyk A, et al. Human endothelial colony forming cells express intracellular CD133 that modulates their vasculogenic properties. Stem Cell Rev Rep. 2019;15:590–600. doi: 10.1007/s12015-019-09881-8. PubMed DOI

Sun S, Meng Y, Li M, Tang X, Hu W, Wu W, et al. CD133(+) endothelial-like stem cells restore neovascularization and promote longevity in progeroid and naturally aged mice. Nat Aging. 2023;3:1401–1414. doi: 10.1038/s43587-023-00512-z. PubMed DOI PMC

Corbeil D, Fargeas CA, Jászai J. CD133 might be a pan marker of epithelial cells with dedifferentiation capacity. Proc Natl Acad Sci U S A. 2014;111:E1451–E1452. doi: 10.1073/pnas.1400195111. PubMed DOI PMC

Jászai J, Graupner S, Tanaka EM, Funk RHW, Huttner WB, Brand M, et al. Spatial distribution of prominin-1 (CD133)—positive cells within germinative zones of the vertebrate brain. PLoS ONE. 2013;8:e63457. doi: 10.1371/journal.pone.0063457. PubMed DOI PMC

Kusaba T, Lalli M, Kramann R, Kobayashi A, Humphreys BD. Differentiated kidney epithelial cells repair injured proximal tubule. Proc Natl Acad Sci U S A. 2014;111:1527–1532. doi: 10.1073/pnas.1310653110. PubMed DOI PMC

Kramann R, Kusaba T, Humphreys BD. Who regenerates the kidney tubule? Nephrol Dial Transplant. 2015;30:903–910. doi: 10.1093/ndt/gfu281. PubMed DOI PMC

Cheng JX, Liu BL, Zhang X. How powerful is CD133 as a cancer stem cell marker in brain tumors? Cancer Treat Rev. 2009;35:403–408. doi: 10.1016/j.ctrv.2009.03.002. PubMed DOI

Miraglia S, Godfrey W, Buck D. A response to AC133 hematopoietic stem cell antigen: human homologue of mouse kidney prominin or distinct member of a novel protein family? Blood. 1998;91:4390–4391. doi: 10.1182/blood.V91.11.4390. PubMed DOI

Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, et al. CD133 expression is not restricted to stem cells, and both CD133(+) and CD133(-) metastatic colon cancer cells initiate tumors. J Clin Invest. 2008;118:2111–2120. PubMed PMC

Fargeas CA, Corbeil D, Huttner WB. AC133 antigen, CD133, prominin-1, prominin-2, etc.: prominin family gene products in need of a rational nomenclature. Stem Cells. 2003;21:506–508. doi: 10.1634/stemcells.21-4-506. PubMed DOI

Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med. 2008;86:1025–1032. doi: 10.1007/s00109-008-0357-8. PubMed DOI PMC

Jaksch M, Múnera J, Bajpai R, Terskikh A, Oshima RG. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res. 2008;68:7882–7886. doi: 10.1158/0008-5472.CAN-08-0723. PubMed DOI PMC

Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoek M, et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res. 2010;70:719–729. doi: 10.1158/0008-5472.CAN-09-1820. PubMed DOI

Bauer N, Wilsch-Bräuninger M, Karbanová J, Fonseca AV, Strauss D, Freund D, et al. Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles—a role of the endocytic–exocytic pathway. EMBO Mol Med. 2011;3:398–409. doi: 10.1002/emmm.201100147. PubMed DOI PMC

Fargeas CA, Karbanová J, Jászai J, Corbeil D. CD133 and membrane microdomains: old facets for future hypotheses. World J Gastroenterol. 2011;17:4149. doi: 10.3748/wjg.v17.i36.4149. PubMed DOI PMC

Barrantes-Freer A, Renovanz M, Eich M, Braukmann A, Sprang B, Spirin P, et al. CD133 expression is not synonymous to immunoreactivity for AC133 and fluctuates throughout the cell cycle in glioma stem-like cells. PLoS ONE. 2015;10:e0130519. doi: 10.1371/journal.pone.0130519. PubMed DOI PMC

Fargeas CA, Büttner E, Corbeil D. Commentary: “Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis”. Front Oncol. 2015;5:91. doi: 10.3389/fonc.2015.00091. PubMed DOI PMC

Cehajic-Kapetanovic J, Birtel J, McClements ME, Shanks ME, Clouston P, Downes SM, et al. Clinical and molecular characterization of PROM1-related retinal degeneration. JAMA Netw Open. 2019;2:e195752. doi: 10.1001/jamanetworkopen.2019.5752. PubMed DOI PMC

Zhang Q, Zulfiqar F, Xiao X, Riazuddin S, Ahmad Z, Caruso R, et al. Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene. Hum Genet. 2007;122:293–299. doi: 10.1007/s00439-007-0395-2. PubMed DOI

Yang Z, Chen Y, Lillo C, Chien J, Yu Z, Michaelides M, et al. Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J Clin Invest. 2008;118:2908–2916. PubMed PMC

Pras E, Abu A, Rotenstreich Y, Avni I, Reish O, Morad Y, et al. Cone-rod dystrophy and a frameshift mutation in the PROM1 gene. Mol Vis. 2009;15:1709–1716. PubMed PMC

Sleeman KE, Kendrick H, Robertson D, Isacke CM, Ashworth A, Smalley MJ. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol. 2007;176:19–26. doi: 10.1083/jcb.200604065. PubMed DOI PMC

Ford MJ, Harwalkar K, Kazemdarvish H, Yamanaka N, Yamanaka Y. CD133/Prom1 marks proximal mouse oviduct epithelial progenitors and adult epithelial cells with a low generative capacity. Biol Open. 2023;12:bio059963. doi: 10.1242/bio.059963. PubMed DOI PMC

Arndt K, Grinenko T, Mende N, Reichert D, Portz M, Ripich T, et al. CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells. Proc Natl Acad Sci U S A. 2013;110:5582–5587. doi: 10.1073/pnas.1215438110. PubMed DOI PMC

Walker TL, Wierick A, Sykes AM, Waldau B, Corbeil D, Carmeliet P, et al. Prominin-1 allows prospective isolation of neural stem cells from the adult murine hippocampus. J Neurosci. 2013;33:3010–3024. doi: 10.1523/JNEUROSCI.3363-12.2013. PubMed DOI PMC

Fargeas CA, Florek M, Huttner WB, Corbeil D. Characterization of Prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem. 2003;278:8586–8596. doi: 10.1074/jbc.M210640200. PubMed DOI

Liu Y, Ren S, Xie L, Cui C, Xing Y, Liu C, et al. Mutation of N-linked glycosylation at Asn548 in CD133 decreases its ability to promote hepatoma cell growth. Oncotarget. 2015;6:20650–20660. doi: 10.18632/oncotarget.4115. PubMed DOI PMC

Corbeil D, Karbanová J, Fargeas CA, Jászai J. Prominin-1 (CD133): molecular and cellular features across species. Adv Exp Med Biol. 2013;777:3–24. doi: 10.1007/978-1-4614-5894-4_1. PubMed DOI

Han Z, Papermaster DS. Identification of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues. Mol Vis. 2011;17:1381–1396. PubMed PMC

Fargeas CA. Prominin-2 and other relatives of CD133. Adv Exp Med Biol. 2013;777:25–40. doi: 10.1007/978-1-4614-5894-4_2. PubMed DOI

Zelhof AC, Hardy RW, Becker A, Zuker CS. Transforming the architecture of compound eyes. Nature. 2006;443:696–699. doi: 10.1038/nature05128. PubMed DOI

Demontis F, Dahmann C. Apical and lateral cell protrusions interconnect epithelial cells in live Drosophila wing imaginal discs. Dev Dyn. 2007;236:3408–3418. doi: 10.1002/dvdy.21324. PubMed DOI

Nie J, Mahato S, Mustill W, Tipping C, Bhattacharya SS, Zelhof AC. Cross species analysis of Prominin reveals a conserved cellular role in invertebrate and vertebrate photoreceptor cells. Dev Biol. 2012;371:312–320. doi: 10.1016/j.ydbio.2012.08.024. PubMed DOI

Mahato S, Nie J, Plachetzki DC, Zelhof AC. A mosaic of independent innovations involving eyes shut are critical for the evolutionary transition from fused to open rhabdoms. Dev Biol. 2018;443:188–202. doi: 10.1016/j.ydbio.2018.09.016. PubMed DOI

Wang X, Zheng H, Jia Z, Lei Z, Li M, Zhuang Q, et al. Drosophila Prominin-like, a homolog of CD133, interacts with ND20 to maintain mitochondrial function. Cell Biosci. 2019;9:101. doi: 10.1186/s13578-019-0365-0. PubMed DOI PMC

McGrail M, Batz L, Noack K, Pandey S, Huang Y, Gu X, et al. Expression of the zebrafish CD133/prominin1 genes in cellular proliferation zones in the embryonic central nervous system and sensory organs. Dev Dyn. 2010;239:1849–1857. doi: 10.1002/dvdy.22307. PubMed DOI

Fargeas CA, Huttner WB, Corbeil D. Nomenclature of prominin-1 (CD133) splice variants—an update. Tissue Antigens. 2007;69:602–606. doi: 10.1111/j.1399-0039.2007.00825.x. PubMed DOI

Thamm K, Graupner S, Werner C, Huttner WB, Corbeil D. Monoclonal antibodies 13A4 and AC133 do not recognize the canine ortholog of mouse and human stem cell antigen prominin-1 (CD133) PLoS ONE. 2016;11:e0164079. doi: 10.1371/journal.pone.0164079. PubMed DOI PMC

Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood. 2004;103:2055–2061. doi: 10.1182/blood-2003-06-1881. PubMed DOI

Kemper K, Tol MJPM, Medema JP. Mouse tissues express multiple splice variants of prominin-1. PLoS ONE. 2010;5:e12325. doi: 10.1371/journal.pone.0012325. PubMed DOI PMC

Choi M-H, Na JE, Yoon YR, Rhyu IJ, Ko Y-G, Baik J-H. Hypomyelination and cognitive impairment in mice lacking CD133 (Prominin-1) Biochem Biophys Res Commun. 2018;502:291–298. doi: 10.1016/j.bbrc.2018.05.072. PubMed DOI

Osmond TL, Broadley KWR, McConnell MJ. Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein. Int J Mol Med. 2010;25:883–888. PubMed

Gopisetty G, Xu J, Sampath D, Colman H, Puduvalli VK. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation. Oncogene. 2013;32:3119–3129. doi: 10.1038/onc.2012.331. PubMed DOI PMC

Sompallae R, Hofmann O, Maher C, Gedye C, Behren A, Vitezic M, et al. A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells. Front Genet. 2013;4:209. doi: 10.3389/fgene.2013.00209. PubMed DOI PMC

Tabu K, Bizen N, Taga T, Tanaka S. Gene regulation of prominin-1 (CD133) in normal and cancerous tissues. Adv Exp Med Biol. 2013;777:73–85. doi: 10.1007/978-1-4614-5894-4_5. PubMed DOI

Tabu K, Kimura T, Sasai K, Wang L, Bizen N, Nishihara H, et al. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Mol Cancer. 2010;9:39. doi: 10.1186/1476-4598-9-39. PubMed DOI PMC

Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S, et al. Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res. 2008;18:1037–1046. doi: 10.1038/cr.2008.270. PubMed DOI

Pleshkan VV, Vinogradova TV, Sverdlov ED. Methylation of the prominin 1 TATA-less main promoters and tissue specificity of their transcript content. Biochim Biophys Acta. 2008;1779:599–605. doi: 10.1016/j.bbagrm.2008.06.002. PubMed DOI

Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE, Easwaran H, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res. 2008;68:8094–8103. doi: 10.1158/0008-5472.CAN-07-6208. PubMed DOI PMC

Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene. 2009;28:209–218. doi: 10.1038/onc.2008.374. PubMed DOI

Godfrey L, Crump NT, O'Byrne S, Lau IJ, Rice S, Harman JR, et al. H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells. Leukemia. 2021;35:90–106. doi: 10.1038/s41375-020-0808-y. PubMed DOI PMC

Guenther MG, Lawton LN, Rozovskaia T, Frampton GM, Levine SS, Volkert TL, et al. Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev. 2008;22:3403–3408. doi: 10.1101/gad.1741408. PubMed DOI PMC

Mak AB, Nixon AML, Moffat J. The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription. Cancer Res. 2012;72:1929–1934. doi: 10.1158/0008-5472.CAN-11-3589. PubMed DOI

You H, Ding W, Rountree CB. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-β. Hepatology. 2010;51:1635–1644. doi: 10.1002/hep.23544. PubMed DOI PMC

Chen Z, Chen Y, Li Y, Lian W, Zheng K, Zhang Y, et al. Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma. Cell Death Dis. 2021;12:615. doi: 10.1038/s41419-021-03882-7. PubMed DOI PMC

Cave DD, Di Guida M, Costa V, Sevillano M, Ferrante L, Heeschen C, et al. TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation. Oncogene. 2020;39:4271–4285. doi: 10.1038/s41388-020-1289-1. PubMed DOI PMC

Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA, Labarthe M-C, et al. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer. 2011;10:94. doi: 10.1186/1476-4598-10-94. PubMed DOI PMC

D'Anello L, Sansone P, Storci G, Mitrugno V, D'Uva G, Chieco P, et al. Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells. Mol Cancer. 2010;9:300. doi: 10.1186/1476-4598-9-300. PubMed DOI PMC

Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol. 2019;20:199–210. doi: 10.1038/s41580-019-0110-x. PubMed DOI

Park EK, Lee JC, Park JW, Bang SY, Yi SA, Kim BK, et al. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53. Cell Death Dis. 2015;6:e1964–e1964. doi: 10.1038/cddis.2015.313. PubMed DOI PMC

Blazek ER, Foutch JL, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133− cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys. 2007;67:1–5. doi: 10.1016/j.ijrobp.2006.09.037. PubMed DOI

Platet N, Liu SY, Atifi ME, Oliver L, Vallette FM, Berger F, et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett. 2007;258:286–290. doi: 10.1016/j.canlet.2007.09.012. PubMed DOI

Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol. 2010;177:1491–1502. doi: 10.2353/ajpath.2010.091021. PubMed DOI PMC

Filatova A, Seidel S, Böğürcü N, Gräf S, Garvalov BK, Acker T. Acidosis acts through HSP90 in a PHD/VHL-independent manner to promote HIF function and stem cell maintenance in glioma. Cancer Res. 2016;76:5845–5856. doi: 10.1158/0008-5472.CAN-15-2630. PubMed DOI

Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene. 2009;28:3949–3959. doi: 10.1038/onc.2009.252. PubMed DOI

Maeda K, Ding Q, Yoshimitsu M, Kuwahata T, Miyazaki Y, Tsukasa K, et al. CD133 modulate HIF-1α expression under hypoxia in EMT phenotype pancreatic cancer stem-like cells. Int J Mol Sci. 2016;17:1025. doi: 10.3390/ijms17071025. PubMed DOI PMC

Qin J, Liu Y, Lu Y, Liu M, Li M, Li J, et al. Hypoxia-inducible factor 1 alpha promotes cancer stem cells-like properties in human ovarian cancer cells by upregulating SIRT1 expression. Sci Rep. 2017;7:10592. doi: 10.1038/s41598-017-09244-8. PubMed DOI PMC

Choudhry H, Harris AL. Advances in hypoxia-inducible factor biology. Cell Metab. 2018;27:281–298. doi: 10.1016/j.cmet.2017.10.005. PubMed DOI

Ohnishi S, Maehara O, Nakagawa K, Kameya A, Otaki K, Fujita H, et al. Hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors. PLoS ONE. 2013;8:e66255. doi: 10.1371/journal.pone.0066255. PubMed DOI PMC

Iida H, Suzuki M, Goitsuka R, Ueno H. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncol. 2012;40:71–79. PubMed

Won C, Kim BH, Yi EH, Choi KJ, Kim EK, Jeong JM, et al. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. Hepatology. 2015;62:1160–1173. doi: 10.1002/hep.27968. PubMed DOI PMC

Matsumoto K, Arao T, Tanaka K, Kaneda H, Kudo K, Fujita Y, et al. mTOR signal and hypoxia-inducible factor-1 regulate CD133 expression in cancer cells. Cancer Res. 2009;69:7160–7164. doi: 10.1158/0008-5472.CAN-09-1289. PubMed DOI

Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, et al. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Cancer Res. 2013;73:406–416. doi: 10.1158/0008-5472.CAN-12-1733. PubMed DOI

Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells. 2010;28:5–16. doi: 10.1002/stem.254. PubMed DOI PMC

Konishi H, Asano N, Imatani A, Kimura O, Kondo Y, Jin X, et al. Notch1 directly induced CD133 expression in human diffuse type gastric cancers. Oncotarget. 2016;7:56598–56607. doi: 10.18632/oncotarget.10967. PubMed DOI PMC

Kumar D, Kumar S, Gorain M, Tomar D, Patil HS, Radharani NNV, et al. Notch1-MAPK signaling axis regulates CD133+ cancer stem cell-mediated melanoma growth and angiogenesis. J Invest Dermatol. 2016;136:2462–2474. doi: 10.1016/j.jid.2016.07.024. PubMed DOI

Katoh Y, Katoh M. Comparative genomics on PROM1 gene encoding stem cell marker CD133. Int J Mol Med. 2007;19:967–970. PubMed

Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. Proc Natl Acad Sci U S A. 2004;101:12682–12687. doi: 10.1073/pnas.0404875101. PubMed DOI PMC

Tang Y, Berlind J, Mavila N. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells. Cell Commun Signal. 2018;16:9. doi: 10.1186/s12964-018-0222-5. PubMed DOI PMC

Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11:252–263. doi: 10.1038/nrm2868. PubMed DOI

Yoshida K, Yamamoto Y, Ochiya T. miRNA signaling networks in cancer stem cells. Regen Ther. 2021;17:1–7. doi: 10.1016/j.reth.2021.01.004. PubMed DOI PMC

Bai H-Y, Liao Y-J, Cai M-Y, Ma N-F, Zhang Q, Chen J-W, et al. Eukaryotic initiation factor 5A2 contributes to the maintenance of CD133(+) hepatocellular carcinoma cells via the c-Myc/microRNA-29b Axis. Stem Cells. 2018;36:180–191. doi: 10.1002/stem.2734. PubMed DOI

Li B, Xu WW, Han L, Chan KT, Tsao SW, Lee NPY, et al. MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF. Oncogene. 2017;36:3986–4000. doi: 10.1038/onc.2017.29. PubMed DOI PMC

Huang S-X, Zhao Z-Y, Weng G-H, He X-Y, Wu C-J, Fu C-Y, et al. Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme. Biochem Biophys Res Commun. 2017;486:1129–1136. doi: 10.1016/j.bbrc.2017.04.008. PubMed DOI

Bourseau-Guilmain E, Griveau A, Benoit J-P, Garcion E. The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS ONE. 2011;6:e25515. doi: 10.1371/journal.pone.0025515. PubMed DOI PMC

Zhou F, Cui C, Ge Y, Chen H, Li Q, Yang Z, et al. α2,3-Sialylation regulates the stability of stem cell marker CD133. J Biochem. 2010;148:273–280. doi: 10.1093/jb/mvq062. PubMed DOI

Hamanoue M, Matsuzaki Y, Sato K-I, Okano HJ, Shibata S, Sato I, et al. Cell surface N-glycans mediated isolation of mouse neural stem cells. J Neurochem. 2009;110:1575–1584. doi: 10.1111/j.1471-4159.2009.06256.x. PubMed DOI

Dowland SN, Madawala RJ, Poon CE, Lindsay LA, Murphy CR. Prominin-1 glycosylation changes throughout early pregnancy in uterine epithelial cells under the influence of maternal ovarian hormones. Reprod Fertil Dev. 2017;29:1194–1208. doi: 10.1071/RD15432. PubMed DOI

Lehnus KS, Donovan LK, Huang X, Zhao N, Warr TJ, Pilkington GJ, et al. CD133 glycosylation is enhanced by hypoxia in cultured glioma stem cells. Int J Oncol. 2013;42:1011–1017. doi: 10.3892/ijo.2013.1787. PubMed DOI

Liu K, Jiang L, Shi Y, Liu B, He Y, Shen Q, et al. Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation. Cell Death Differ. 2022;29:1834–1849. doi: 10.1038/s41418-022-00969-2. PubMed DOI PMC

Wei Y, Chen Q, Huang S, Liu Y, Li Y, Xing Y, et al. The interaction between DNMT1 and high-mannose CD133 maintains the slow-cycling state and tumorigenic potential of glioma stem cell. Adv Sci. 2022;9:2202216. doi: 10.1002/advs.202202216. PubMed DOI PMC

Mak AB, Blakely KM, Williams RA, Penttilä P-A, Shukalyuk AI, Osman KT, et al. CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem. 2011;286:41046–41056. doi: 10.1074/jbc.M111.261545. PubMed DOI PMC

Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest. 2008;88:808–815. doi: 10.1038/labinvest.2008.57. PubMed DOI

Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu ED, Gingras D, et al. The stem cell marker CD133 (Prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry. 2009;48:3998–4007. doi: 10.1021/bi900159d. PubMed DOI

Mak AB, Pehar M, Nixon AML, Williams RA, Uetrecht AC, Puglielli L, et al. Post-translational regulation of CD133 by ATase1/ATase2-mediated lysine acetylation. J Mol Biol. 2014;426:2175–2182. doi: 10.1016/j.jmb.2014.02.012. PubMed DOI PMC

Wei Y, Jiang Y, Zou F, Liu Y, Wang S, Xu N, et al. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells. Proc Natl Acad Sci U S A. 2013;110:6829–6834. doi: 10.1073/pnas.1217002110. PubMed DOI PMC

Chen Y-S, Wu M-J, Huang C-Y, Lin S-C, Chuang T-H, Yu C-C, et al. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS ONE. 2011;6:e28053. doi: 10.1371/journal.pone.0028053. PubMed DOI PMC

Yang F, Xing Y, Li Y, Chen X, Jiang J, Ai Z, et al. Monoubiquitination of cancer stem cell marker CD133 at lysine 848 regulates its secretion and promotes cell migration. Mol Cell Biol. 2018;38:e00024–e118. doi: 10.1128/MCB.00024-18. PubMed DOI PMC

Babst M, Odorizzi G, Estepa EJ, Emr SD. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic. 2000;1:248–258. doi: 10.1034/j.1600-0854.2000.010307.x. PubMed DOI

Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14:677–685. doi: 10.1038/ncb2502. PubMed DOI

Ding Y, Dellisanti CD, Ko MH, Czajkowski C, Puglielli L. The endoplasmic reticulum-based acetyltransferases, ATase1 and ATase2, associate with the oligosaccharyltransferase to acetylate correctly folded polypeptides. J Biol Chem. 2014;289:32044–32055. doi: 10.1074/jbc.M114.585547. PubMed DOI PMC

Jászai J, Fargeas CA, Florek M, Huttner WB, Corbeil D. Focus on molecules: prominin-1 (CD133) Exp Eye Res. 2007;85:585–586. doi: 10.1016/j.exer.2006.03.022. PubMed DOI

Gurudev N, Florek M, Corbeil D, Knust E. Prominent role of prominin in the retina. Adv Exp Med Biol. 2013;777:55–71. doi: 10.1007/978-1-4614-5894-4_4. PubMed DOI

Goldberg AFX, Moritz OL, Williams DS. Molecular basis for photoreceptor outer segment architecture. Prog Retin Eye Res. 2016;55:52–81. doi: 10.1016/j.preteyeres.2016.05.003. PubMed DOI PMC

Dellett M, Sasai N, Nishide K, Becker S, Papadaki V, Limb GA, et al. Genetic background and light-dependent progression of photoreceptor cell degeneration in prominin-1 knockout Mice. Invest Ophthalmol Vis Sci. 2015;56:164–176. doi: 10.1167/iovs.14-15479. PubMed DOI

Han Z, Anderson DW, Papermaster DS. Prominin-1 localizes to the open rims of outer segment lamellae in xenopus laevis rod and cone photoreceptors. Invest Ophthalmol Vis Sci. 2012;53:361–373. doi: 10.1167/iovs.11-8635. PubMed DOI PMC

Carr BJ, Stanar P, Moritz OL. Distinct roles for prominin-1 and photoreceptor cadherin in outer segment disc morphogenesis in CRISPR-altered X. laevis. J Cell Sci. 2021;134:jcs253906. PubMed

Lu Z, Hu X, Reilly J, Jia D, Liu F, Yu S, et al. Deletion of the transmembrane protein Prom1b in zebrafish disrupts outer-segment morphogenesis and causes photoreceptor degeneration. J Biol Chem. 2019;294:13953–13963. doi: 10.1074/jbc.RA119.008618. PubMed DOI PMC

Corbeil D, Fargeas CA, Jászai J. Deciphering the roles of prominins in the visual system. J Biol Chem. 2019;294:17166. doi: 10.1074/jbc.L119.011198. PubMed DOI PMC

Thamm K, Šimaitė D, Karbanová J, Bermúdez V, Reichert D, Morgenstern A, et al. Prominin-1 (CD133) modulates the architecture and dynamics of microvilli. Traffic. 2019;20:39–60. doi: 10.1111/tra.12618. PubMed DOI

Hori A, Nishide K, Yasukuni Y, Haga K, Kakuta W, Ishikawa Y, et al. Prominin-1 modulates Rho/ROCK-mediated membrane morphology and calcium-dependent intracellular chloride flux. Sci Rep. 2019;9:15911. doi: 10.1038/s41598-019-52040-9. PubMed DOI PMC

Freund D, Bauer N, Boxberger S, Feldmann S, Streller U, Ehninger G, et al. Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev. 2006;15:815–829. doi: 10.1089/scd.2006.15.815. PubMed DOI

Spencer WJ, Schneider NF, Lewis TR, Castillo CM, Skiba NP, Arshavsky VY. The WAVE complex drives the morphogenesis of the photoreceptor outer segment cilium. Proc Natl Acad Sci U S A. 2023;120:e2215011120. doi: 10.1073/pnas.2215011120. PubMed DOI PMC

Goetz SC, Anderson KV. The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet. 2010;11:331–344. doi: 10.1038/nrg2774. PubMed DOI PMC

Singer D, Thamm K, Zhuang H, Karbanová J, Gao Y, Walker JV, et al. Prominin-1 controls stem cell activation by orchestrating ciliary dynamics. EMBO J. 2019;38:e99845. doi: 10.15252/embj.201899845. PubMed DOI PMC

Jászai J, Thamm K, Karbanová J, Janich P, Fargeas CA, Huttner WB, et al. Prominins control ciliary length throughout the animal kingdom: new lessons from human prominin-1 and zebrafish prominin-3. J Biol Chem. 2020;295:6007–6022. doi: 10.1074/jbc.RA119.011253. PubMed DOI PMC

Florek M, Bauer N, Janich P, Wilsch-Braeuninger M, Fargeas CA, Marzesco AM, et al. Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res. 2007;328:31–47. doi: 10.1007/s00441-006-0324-z. PubMed DOI

Janich P, Corbeil D. GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells. FEBS Lett. 2007;581:1783–1787. doi: 10.1016/j.febslet.2007.03.065. PubMed DOI

Larkins CE, Aviles GDG, East MP, Kahn RA, Caspary T. Arl13b regulates ciliogenesis and the dynamic localization of Shh signaling proteins. Mol Biol Cell. 2011;22:4694–4703. doi: 10.1091/mbc.e10-12-0994. PubMed DOI PMC

Lu H, Toh MT, Narasimhan V, Thamilselvam SK, Choksi SP, Roy S. A function for the Joubert syndrome protein Arl13b in ciliary membrane extension and ciliary length regulation. Dev Biol. 2015;397:225–236. doi: 10.1016/j.ydbio.2014.11.009. PubMed DOI

Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell. 2007;129:1351–1363. doi: 10.1016/j.cell.2007.04.035. PubMed DOI PMC

Ran J, Yang Y, Li D, Liu M, Zhou J. Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly. Sci Rep. 2015;5:12917. doi: 10.1038/srep12917. PubMed DOI PMC

Izumi H, Li Y, Shibaki M, Mori D, Yasunami M, Sato S, et al. Recycling endosomal CD133 functions as an inhibitor of autophagy at the pericentrosomal region. Sci Rep. 2019;9:2236. doi: 10.1038/s41598-019-39229-8. PubMed DOI PMC

Marzesco AM, Janich P, Wilshch-Bräuninger M, Dubreuil V, Langenfeld K, Corbeil D, et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci. 2005;118:2849–2858. doi: 10.1242/jcs.02439. PubMed DOI

Dubreuil V, Marzesco AM, Corbeil D, Huttner WB, Wilsch-Brauninger M. Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1. J Cell Biol. 2007;176:483–495. doi: 10.1083/jcb.200608137. PubMed DOI PMC

Mirzadeh Z, Merkle FT, Soriano-Navarro M, Garcia-Verdugo JM, Alvarez-Buylla A. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell. 2008;3:265–278. doi: 10.1016/j.stem.2008.07.004. PubMed DOI PMC

Codega P, Silva-Vargas V, Paul A, Maldonado-Soto AR, Deleo AM, Pastrana E, et al. Prospective identification and purification of quiescent adult neural stem cells from their in vivo niche. Neuron. 2014;82:545–559. doi: 10.1016/j.neuron.2014.02.039. PubMed DOI PMC

Coskun V, Wu H, Blanchi B, Tsao S, Kim K, Zhao J, et al. CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain. Proc Natl Acad Sci U S A. 2008;105:1026–1031. doi: 10.1073/pnas.0710000105. PubMed DOI PMC

Zhong A, Short C, Xu J, Fernandez GE, Malkoff N, Noriega N, et al. Prominin-1 promotes restitution of the murine extrahepatic biliary luminal epithelium following cholestatic liver injury. Hepatol Commun. 2023;7:e0018. doi: 10.1097/HC9.0000000000000018. PubMed DOI PMC

Jászai J, Corbeil D, Fargeas CA. Comprehensive overview of CD133 biology in neural tissues across species. In: Pruszak J, editor. Neural surface antigens–from basic biology towards biomedical applications. Academic Press; 2015. p. 113–129.

Bachor TP, Karbanová J, Büttner E, Bermúdez V, Marquioni-Ramella M, Carmeliet P, et al. Early ciliary and prominin-1 dysfunctions precede neurogenesis impairment in a mouse model of type 2 diabetes. Neurobiol Dis. 2017;108:13–28. doi: 10.1016/j.nbd.2017.07.010. PubMed DOI

Serra CFH, Liu H, Qian J, Mori M, Lu J, Cardoso WV. Prominin 1 and Notch regulate ciliary length and dynamics in multiciliated cells of the airway epithelium. iScience. 2022;25:104751. doi: 10.1016/j.isci.2022.104751. PubMed DOI PMC

Badano JL, Mitsuma N, Beales PL, Katsanis N. The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet. 2006;7:125–148. doi: 10.1146/annurev.genom.7.080505.115610. PubMed DOI

Xiao YS, Liang J, Gao M, Sun JR, Liu Y, Chen JQ, et al. Deletion of prominin-1 in mice results in disrupted photoreceptor outer segment protein homeostasis. Int J Ophthalmol. 2021;14:1334–1344. doi: 10.18240/ijo.2021.09.07. PubMed DOI PMC

Fargeas CA, Jászai J, Corbeil D. Prominin-1 expression in the testis/epididymis and fertility. Reprod Med Biol. 2023;22:e12544. doi: 10.1002/rmb2.12544. PubMed DOI PMC

Karim BO, Rhee KJ, Liu G, Yun K, Brant SR. Prom1 function in development, intestinal inflammation, and intestinal tumorigenesis. Front Oncol. 2014;4:323. doi: 10.3389/fonc.2014.00323. PubMed DOI PMC

Nishide K, Nakatani Y, Kiyonari H, Kondo T. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS ONE. 2009;4:e6869. doi: 10.1371/journal.pone.0006869. PubMed DOI PMC

Jászai J, Fargeas CA, Haase M, Farkas LM, Huttner WB, Corbeil D. Robust expression of Prominin-2 all along the adult male reproductive system and urinary bladder. Histochem Cell Biol. 2008;130:749–759. doi: 10.1007/s00418-008-0445-4. PubMed DOI

Asano A, Nelson JL, Zhang S, Travis AJ. Characterization of the proteomes associating with three distinct membrane raft sub-types in murine sperm. Proteomics. 2010;10:3494–3505. doi: 10.1002/pmic.201000002. PubMed DOI PMC

Yukselten Y, Aydos OSE, Sunguroglu A, Aydos K. Investigation of CD133 and CD24 as candidate azoospermia markers and their relationship with spermatogenesis defects. Gene. 2019;706:211–221. doi: 10.1016/j.gene.2019.04.028. PubMed DOI

Matsukuma H, Kobayashi Y, Oka S, Higashijima F, Kimura K, Yoshihara E, et al. Prominin-1 deletion results in spermatogenic impairment, sperm morphological defects, and infertility in mice. Reprod Med Biol. 2023;22:e12514. doi: 10.1002/rmb2.12514. PubMed DOI PMC

Röper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol. 2000;2:582–592. doi: 10.1038/35023524. PubMed DOI

Karbanová J, Lorico A, Bornhäuser M, Corbeil D, Fargeas CA. Prominin-1/CD133: lipid raft association, detergent resistance, and immunodetection. Stem Cells Transl Med. 2018;7:155–160. doi: 10.1002/sctm.17-0223. PubMed DOI PMC

Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18:361–374. doi: 10.1038/nrm.2017.16. PubMed DOI PMC

Ikonen E, Simons K. Protein and lipid sorting from the trans-Golgi network to the plasma membrane in polarized cells. Semin Cell Dev Biol. 1998;9:503–509. doi: 10.1006/scdb.1998.0258. PubMed DOI

Huttner WB, Zimmerberg J. Implications of lipid microdomains for membrane curvature, budding and fission. Curr Opin Cell Biol. 2001;13:478–484. doi: 10.1016/S0955-0674(00)00239-8. PubMed DOI

Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31–39. doi: 10.1038/35036052. PubMed DOI

Zhang S, Zhu N, Li HF, Gu J, Zhang CJ, Liao DF, et al. The lipid rafts in cancer stem cell: a target to eradicate cancer. Stem Cell Res Ther. 2022;13:432. doi: 10.1186/s13287-022-03111-8. PubMed DOI PMC

Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 1992;68:533–544. doi: 10.1016/0092-8674(92)90189-J. PubMed DOI

Lingwood D, Simons K. Detergent resistance as a tool in membrane research. Nat Protoc. 2007;2:2159–2165. doi: 10.1038/nprot.2007.294. PubMed DOI

Corbeil D, Marzesco AM, Wilsch-Bräuninger M, Huttner WB. The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett. 2010;584:1659–1664. doi: 10.1016/j.febslet.2010.01.050. PubMed DOI

Taïeb N, Maresca M, Guo X-J, Garmy N, Fantini J, Yahi N. The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett. 2009;278:164–173. doi: 10.1016/j.canlet.2009.01.013. PubMed DOI

Gillette JM, Larochelle A, Dunbar CE, Lippincott-Schwartz J. Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nat Cell Biol. 2009;11:303–311. doi: 10.1038/ncb1838. PubMed DOI PMC

Freund D, Fonseca A-V, Janich P, Bornhäuser M, Corbeil D. Differential expression of biofunctional GM1 and GM3 gangliosides within the plastic-adherent multipotent mesenchymal stromal cell population. Cytotherapy. 2010;12:131–142. doi: 10.3109/14653240903476438. PubMed DOI

Mazerik JN, Tyska MJ. Myosin-1A targets to microvilli using multiple membrane binding motifs in the tail homology 1 (TH1) domain. J Biol Chem. 2012;287:13104–13115. doi: 10.1074/jbc.M111.336313. PubMed DOI PMC

Hokanson DE, Ostap EM. Myo1c binds tightly and specifically to phosphatidylinositol 4,5-bisphosphate and inositol 1,4,5-trisphosphate. Proc Natl Acad Sci U S A. 2006;103:3118–3123. doi: 10.1073/pnas.0505685103. PubMed DOI PMC

Insall RH, Weiner OD. PIP3, PIP2, and cell movement—similar messages, different meanings? Dev Cell. 2001;1:743–747. doi: 10.1016/S1534-5807(01)00086-7. PubMed DOI PMC

Spillane M, Ketschek A, Jones SL, Korobova F, Marsick B, Lanier L, et al. The actin nucleating Arp2/3 complex contributes to the formation of axonal filopodia and branches through the regulation of actin patch precursors to filopodia. Dev Neurobiol. 2011;71:747–758. doi: 10.1002/dneu.20907. PubMed DOI PMC

Iglič A, Hägerstrand H, Veranič P, Plemenitaš A, Kralj-Iglič V. Curvature-induced accumulation of anisotropic membrane components and raft formation in cylindrical membrane protrusions. J Theor Biol. 2006;240:368–373. doi: 10.1016/j.jtbi.2005.09.020. PubMed DOI

Schara K, Jansa V, Sustar V, Dolinar D, Pavlic JI, Lokar M, et al. Mechanisms for the formation of membranous nanostructures in cell-to-cell communication. Cell Mol Biol Lett. 2009;14:636–656. doi: 10.2478/s11658-009-0018-0. PubMed DOI PMC

Kabaso D, Bobrovska N, Góźdź W, Gov N, Kralj-Iglič V, Veranič P, et al. On the role of membrane anisotropy and BAR proteins in the stability of tubular membrane structures. J Biomech. 2012;45:231–238. doi: 10.1016/j.jbiomech.2011.10.039. PubMed DOI

Kinnebrew M, Iverson EJ, Patel BB, Pusapati GV, Kong JH, Johnson KA, et al. Cholesterol accessibility at the ciliary membrane controls hedgehog signaling. Elife. 2019;8:e50051. doi: 10.7554/eLife.50051. PubMed DOI PMC

Radhakrishnan A, Rohatgi R, Siebold C. Cholesterol access in cellular membranes controls Hedgehog signaling. Nat Chem Biol. 2020;16:1303–1313. doi: 10.1038/s41589-020-00678-2. PubMed DOI PMC

Adhyapak P, Kapoor S. Membrane dynamics in health and disease: impact on cellular signalling. J Membr Biol. 2019;252:213–226. doi: 10.1007/s00232-019-00087-0. PubMed DOI

Sasaki A, Kamiyama T, Yokoo H, Nakanishi K, Kubota K, Haga H, et al. Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. Oncol Rep. 2010;24:537–546. doi: 10.3892/or_00000890. PubMed DOI

Zhang J, Guo X, Chang DY, Rosen DG, Mercado-Uribe I, Liu J. CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol. 2012;25:456–464. doi: 10.1038/modpathol.2011.170. PubMed DOI PMC

Brescia P, Ortensi B, Fornasari L, Levi D, Broggi G, Pelicci G. CD133 is essential for glioblastoma stem cell maintenance. Stem Cells. 2013;31:857–869. doi: 10.1002/stem.1317. PubMed DOI

Chen Y-L, Lin P-Y, Ming Y-Z, Huang W-C, Chen R-F, Chen P-M, et al. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients. BMC Cancer. 2017;17:474. doi: 10.1186/s12885-017-3460-9. PubMed DOI PMC

Adini A, Adini I, Ghosh K, Benny O, Pravda E, Hu R, et al. The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action. Angiogenesis. 2013;16:405–416. doi: 10.1007/s10456-012-9323-8. PubMed DOI

Chen H, Luo Z, Dong L, Tan Y, Yang J, Feng G, et al. CD133/Prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival. PLoS ONE. 2013;8:e56878. doi: 10.1371/journal.pone.0056878. PubMed DOI PMC

Sun H, Zhang M, Cheng K, Li P, Han S, Li R, et al. Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy. Oncotarget. 2016;7:76238–76249. doi: 10.18632/oncotarget.12803. PubMed DOI PMC

Bhattacharya S, Yin J, Winborn CS, Zhang Q, Yue J, Chaum E. Prominin-1 is a novel regulator of autophagy in the human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2017;58:2366. doi: 10.1167/iovs.16-21162. PubMed DOI PMC

Cha-Molstad H, Yu JE, Feng Z, Lee SH, Kim JG, Yang P, et al. p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Nat Commun. 2017;8:102. doi: 10.1038/s41467-017-00085-7. PubMed DOI PMC

Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 2010;29:1792–1802. doi: 10.1038/emboj.2010.74. PubMed DOI PMC

Joachim J, Jefferies HB, Razi M, Frith D, Snijders AP, Chakravarty P, et al. Activation of ULK kinase and autophagy by GABARAP trafficking from the centrosome is regulated by WAC and GM130. Mol Cell. 2015;60:899–913. doi: 10.1016/j.molcel.2015.11.018. PubMed DOI PMC

Rogov V, Dötsch V, Johansen T, Kirkin V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell. 2014;53:167–178. doi: 10.1016/j.molcel.2013.12.014. PubMed DOI

Fonseca AV, Bauer N, Corbeil D. The stem cell marker CD133 meets the endosomal compartment–new insights into the cell division of hematopoietic stem cells. Blood Cells Mol Dis. 2008;41:194–195. doi: 10.1016/j.bcmd.2008.04.004. PubMed DOI

Pine SR, Ryan BM, Varticovski L, Robles AI, Harris CC. Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proc Natl Acad Sci U S A. 2010;107:2195–2200. doi: 10.1073/pnas.0909390107. PubMed DOI PMC

Lathia JD, Hitomi M, Gallagher J, Gadani SP, Adkins J, Vasanji A, et al. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis. 2011;2:e200. doi: 10.1038/cddis.2011.80. PubMed DOI PMC

Izumi H, Li Y, Yasunami M, Sato S, Mae T, Kaneko Y, et al. Asymmetric pericentrosomal CD133 endosomes induce the unequal autophagic activity during cytokinesis in CD133-positive human neuroblastoma cells. Stem Cells. 2022;40:371–384. doi: 10.1093/stmcls/sxac007. PubMed DOI

Hitomi M, Chumakova AP, Silver DJ, Knudsen AM, Pontius WD, Murphy S, et al. Asymmetric cell division promotes therapeutic resistance in glioblastoma stem cells. JCI Insight. 2021;6:e130510. doi: 10.1172/jci.insight.130510. PubMed DOI PMC

Kosodo Y, Röper K, Haubensak W, Marzesco AM, Corbeil D, Huttner WB. Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J. 2004;23:2314–2324. doi: 10.1038/sj.emboj.7600223. PubMed DOI PMC

Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12:823–830. doi: 10.1038/ncb0910-823. PubMed DOI PMC

Pampliega O, Orhon I, Patel B, Sridhar S, Díaz-Carretero A, Beau I, et al. Functional interaction between autophagy and ciliogenesis. Nature. 2013;502:194–200. doi: 10.1038/nature12639. PubMed DOI PMC

Orhon I, Dupont N, Pampliega O, Cuervo AM, Codogno P. Autophagy and regulation of cilia function and assembly. Cell Death Differ. 2015;22:389–397. doi: 10.1038/cdd.2014.171. PubMed DOI PMC

Cao M, Zhong Q. Cilia in autophagy and cancer. Cilia. 2015;5:4. doi: 10.1186/s13630-016-0027-3. PubMed DOI PMC

Morleo F. The autophagy-cilia axis: an intricate relationship. Cells. 2019;8:905. doi: 10.3390/cells8080905. PubMed DOI PMC

Nunukova A, Neradil J, Skoda J, Jaros J, Hampl A, Sterba J, et al. Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines. Int J Mol Med. 2015;36:65–72. doi: 10.3892/ijmm.2015.2210. PubMed DOI PMC

Skoda J, Nunukova A, Loja T, Zambo I, Neradil J, Mudry P, et al. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice. Tumor Biol. 2016;37:9535–9548. doi: 10.1007/s13277-016-4837-0. PubMed DOI

Cantile M, Collina F, D'Aiuto M, Rinaldo M, Pirozzi G, Borsellino C, et al. Nuclear localization of cancer stem cell marker CD133 in triple-negative breast cancer: a case report. Tumori. 2013;99:e245–250. doi: 10.1177/030089161309900523. PubMed DOI

Huang MJ, Zhu HJ, Feng J, Ni SS, Huang JF. High CD133 expression in the nucleus and cytoplasm predicts poor prognosis in non-small cell lung cancer. Dis Markers. 2015;2015:986095. doi: 10.1155/2015/986095. PubMed DOI PMC

Rappa G, Santos MF, Green TM, Karbanová J, Hassler J, Bai Y, et al. Nuclear transport of cancer extracellular vesicle-derived biomaterials through nuclear envelope invagination-associated late endosomes. Oncotarget. 2017;8:14443–14461. doi: 10.18632/oncotarget.14804. PubMed DOI PMC

Lee YM, Yeo MK, Seong IO, Kim KH. Nuclear expression of CD133 is associated with good prognosis in patients with colorectal adenocarcinoma. Anticancer Res. 2018;38:4819–4826. doi: 10.21873/anticanres.12792. PubMed DOI

Briscoe J, Thérond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14:416–429. doi: 10.1038/nrm3598. PubMed DOI

Tierney MT, Aydogdu T, Sala D, Malecova B, Gatto S, Puri PL, et al. STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med. 2014;20:1182–1186. doi: 10.1038/nm.3656. PubMed DOI PMC

Bhattacharya S, Yin J, Yang C, Wang Y, Sims M, Pfeffer LM, et al. STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells. J Cell Mol Med. 2022;26:3873–3890. doi: 10.1111/jcmm.17421. PubMed DOI PMC

Zheng H, Zhang Y, Chen Y, Guo P, Wang X, Yuan X, et al. Prominin-like, a homolog of mammalian CD133, suppresses di lp6 and TOR signaling to maintain body size and weight in Drosophila. FASEB J. 2019;33:2646–2658. doi: 10.1096/fj.201800123R. PubMed DOI

Ryu TH, Yeom E, Subramanian M, Lee K-S, Yu K. Prominin-like regulates longevity and glucose metabolism via insulin signaling in drosophila. J Gerontol A Biol Sci Med Sci. 2018;74:1557–1563. doi: 10.1093/gerona/gly291. PubMed DOI

Sepp KJ, Hong P, Lizarraga SB, Liu JS, Mejia LA, Walsh CA, et al. Identification of neural outgrowth genes using genome-wide RNAi. PLoS Genet. 2008;4:e1000111. doi: 10.1371/journal.pgen.1000111. PubMed DOI PMC

Yang C, Yang Y, Gupta N, Liu X, He A, Liu L, et al. Pentaspan membrane glycoprotein, prominin-1, is involved in glucose metabolism and cytoskeleton alteration. Biochemistry (Mosc) 2007;72:854–862. doi: 10.1134/S000629790708007X. PubMed DOI

Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR, et al. CD133 is a marker of bioenergetic stress in human glioma. PLoS ONE. 2008;3:e3655. doi: 10.1371/journal.pone.0003655. PubMed DOI PMC

Zobalova R, Prokopova K, Stantic M, Stapelberg M, Dong LF, Ralph SJ, et al. The potential role of CD133 in immune surveillance and apoptosis: a mitochondrial connection? Antioxid Redox Signal. 2011;15:2989–3002. doi: 10.1089/ars.2010.3785. PubMed DOI

Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–1172. doi: 10.1084/jem.183.3.1161. PubMed DOI PMC

van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213–228. doi: 10.1038/nrm.2017.125. PubMed DOI

Arena GO, Forte S, Abdouh M, Vanier C, Corbeil D, Lorico A. Horizontal transfer of malignant traits and the involvement of extracellular vesicles in metastasis. Cells. 2023;12:1566. doi: 10.3390/cells12121566. PubMed DOI PMC

Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. doi: 10.3402/jev.v4.27066. PubMed DOI PMC

Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383. doi: 10.1083/jcb.201211138. PubMed DOI PMC

Corbeil D, Santos MF, Karbanová J, Kurth T, Rappa G, Lorico A. Uptake and fate of extracellular membrane vesicles: nucleoplasmic reticulum-associated late endosomes as a new gate to intercellular communication. Cells. 2020;9:1931. doi: 10.3390/cells9091931. PubMed DOI PMC

Rilla K. Diverse plasma membrane protrusions act as platforms for extracellular vesicle shedding. J Extracell Vesicles. 2021;10:e12148. doi: 10.1002/jev2.12148. PubMed DOI PMC

Gustafson CM, Gammill LS. Extracellular vesicles and membrane protrusions in developmental signaling. J Dev Biol. 2022;10:39. doi: 10.3390/jdb10040039. PubMed DOI PMC

Marzesco AM, Wilsch-Bräuninger M, Dubreuil V, Janich P, Langenfeld K, Thiele C, et al. Release of extracellular membrane vesicles from microvilli of epithelial cells is enhanced by depleting membrane cholesterol. FEBS Lett. 2009;583:897–902. doi: 10.1016/j.febslet.2009.01.048. PubMed DOI

Corbeil D, Marzesco AM, Fargeas CA, Huttner WB. Prominin-1: a distinct cholesterol-binding membrane protein and the organisation of the apical plasma membrane of epithelial cells. Subcell Biochem. 2010;51:399–423. doi: 10.1007/978-90-481-8622-8_14. PubMed DOI

de Poret A, Dibsy R, Merida P, Trausch A, Inamdar K, Muriaux D. Extracellular vesicles containing the I-BAR protein IRSp53 are released from the cell plasma membrane in an Arp2/3 dependent manner. Biol Cell. 2022;114:259–275. doi: 10.1111/boc.202100095. PubMed DOI

Nager AR, Goldstein JS, Herranz-Pérez V, Portran D, Ye F, Garcia-Verdugo JM, et al. An actin network dispatches ciliary GPCRs into extracellular vesicles to modulate signaling. Cell. 2017;168:252–263.e214. doi: 10.1016/j.cell.2016.11.036. PubMed DOI PMC

Ettinger AW, Wilsch-Bräuninger M, Marzesco A-M, Bickle M, Lohmann A, Maliga Z, et al. Proliferating versus differentiating stem and cancer cells exhibit distinct midbody-release behaviour. Nat Commun. 2011;2:503. doi: 10.1038/ncomms1511. PubMed DOI PMC

McConnell RE, Higginbotham JN, Shifrin DA, Jr, Tabb DL, Coffey RJ, Tyska MJ. The enterocyte microvillus is a vesicle-generating organelle. J Cell Biol. 2009;185:1285–1298. doi: 10.1083/jcb.200902147. PubMed DOI PMC

Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, et al. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19:1875–1885. doi: 10.1016/j.cub.2009.09.059. PubMed DOI PMC

Hurbain I, Macé A-S, Romao M, Prince E, Sengmanivong L, Ruel L, et al. Microvilli-derived extracellular vesicles carry Hedgehog morphogenic signals for Drosophila wing imaginal disc development. Curr Biol. 2022;32:361–373.e366. doi: 10.1016/j.cub.2021.11.023. PubMed DOI

Shenoy GN, Loyall J, Berenson CS, Kelleher RJ, Iyer V, Balu-Iyer SV, et al. Sialic acid-dependent inhibition of T cells by exosomal ganglioside GD3 in ovarian tumor microenvironments. J Immunol. 2018;201:3750–3758. doi: 10.4049/jimmunol.1801041. PubMed DOI PMC

Marzesco AM. Prominin-1-containing membrane vesicles: origins, formation, and utility. Adv Exp Med Biol. 2013;777:41–54. doi: 10.1007/978-1-4614-5894-4_3. PubMed DOI

Rappa G, Mercapide J, Anzanello F, Pope RM, Lorico A. Biochemical and biological characterization of exosomes containing prominin-1/CD133. Mol Cancer. 2013;12:62. doi: 10.1186/1476-4598-12-62. PubMed DOI PMC

Rappa G, Mercapide J, Anzanello F, Le TT, Johlfs MG, Fiscus RR, et al. Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells. Exp Cell Res. 2013;319:810–819. doi: 10.1016/j.yexcr.2013.01.003. PubMed DOI PMC

Lucchetti D, Calapa F, Palmieri V, Fanali C, Carbone F, Papa A, et al. Differentiation affects the release of exosomes from colon cancer cells and their ability to modulate the behavior of recipient cells. Am J Pathol. 2017;187:1633–1647. doi: 10.1016/j.ajpath.2017.03.015. PubMed DOI

Kang M, Kim S, Ko J. Roles of CD133 in microvesicle formation and oncoprotein trafficking in colon cancer. FASEB J. 2019;33:4248–4260. doi: 10.1096/fj.201802018R. PubMed DOI

Moon B-S, Jeong W-J, Park J, Kim TI, Min DS, Choi K-Y. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. J Natl Cancer Inst. 2014;106:djt373. doi: 10.1093/jnci/djt373. PubMed DOI

Deng Y, Wang L, Tan S, Kim GP, Dou R, Chen D, et al. KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer. Mol Oncol. 2015;9:1341–1347. doi: 10.1016/j.molonc.2015.03.006. PubMed DOI PMC

Huttner HB, Janich P, Kohrmann M, Jászai J, Siebzehnrubl F, Blumcke I, et al. The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells. 2008;26:698–705. doi: 10.1634/stemcells.2007-0639. PubMed DOI

Huttner HB, Corbeil D, Thirmeyer C, Coras R, Köhrmann M, Mauer C, et al. Increased membrane shedding—indicated by an elevation of CD133-enriched membrane particles—into the CSF in partial epilepsy. Epilepsy Res. 2012;99:101–106. doi: 10.1016/j.eplepsyres.2011.10.029. PubMed DOI

Bobinger T, May L, Lücking H, Kloska SP, Burkardt P, Spitzer P, et al. CD133-positive membrane particles in cerebrospinal fluid of patients with inflammatory and degenerative neurological diseases. Front Cell Neurosci. 2017;11:77. doi: 10.3389/fncel.2017.00077. PubMed DOI PMC

Bobinger T, Roeder SS, Spruegel MI, Froehlich K, Beuscher VD, Hoelter P, et al. Variation of membrane particle–bound CD133 in cerebrospinal fluid of patients with subarachnoid and intracerebral hemorrhage. J Neurosurg. 2020;134:1–8. doi: 10.3171/2019.11.JNS191861. PubMed DOI

Dimuccio V, Ranghino A, Praticò Barbato L, Fop F, Biancone L, Camussi G, et al. Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage. PLoS ONE. 2014;9:e104490. doi: 10.1371/journal.pone.0104490. PubMed DOI PMC

Dimuccio V, Peruzzi L, Brizzi MF, Cocchi E, Fop F, Boido A, et al. Acute and chronic glomerular damage is associated with reduced CD133 expression in urinary extracellular vesicles. Am J Physiol Renal Physiol. 2020;318:F486–F495. doi: 10.1152/ajprenal.00404.2019. PubMed DOI

Burrello J, Monticone S, Burrello A, Bolis S, Cristalli CP, Comai G, et al. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant. Nephrol Dial Transplant. 2023;38:764–777. doi: 10.1093/ndt/gfac259. PubMed DOI PMC

Ranghino A, Dimuccio V, Papadimitriou E, Bussolati B. Extracellular vesicles in the urine: markers and mediators of tissue damage and regeneration. Clin Kidney J. 2015;8:23–30. doi: 10.1093/ckj/sfu136. PubMed DOI PMC

Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science. 2004;303:1007–1010. doi: 10.1126/science.1093133. PubMed DOI

Cordero Cervantes D, Zurzolo C. Peering into tunneling nanotubes-The path forward. EMBO J. 2021;40:e105789. doi: 10.15252/embj.2020105789. PubMed DOI PMC

Kolba MD, Dudka W, Zaręba-Kozioł M, Kominek A, Ronchi P, Turos L, et al. Tunneling nanotube-mediated intercellular vesicle and protein transfer in the stroma-provided imatinib resistance in chronic myeloid leukemia cells. Cell Death Dis. 2019;10:817. doi: 10.1038/s41419-019-2045-8. PubMed DOI PMC

Wang X, Gerdes HH. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 2015;22:1181–1191. doi: 10.1038/cdd.2014.211. PubMed DOI PMC

Wang X, Veruki ML, Bukoreshtliev NV, Hartveit E, Gerdes HH. Animal cells connected by nanotubes can be electrically coupled through interposed gap-junction channels. Proc Natl Acad Sci U S A. 2010;107:17194–17199. doi: 10.1073/pnas.1006785107. PubMed DOI PMC

Wang X, Bukoreshtliev NV, Gerdes HH. Developing neurons form transient nanotubes facilitating electrical coupling and calcium signaling with distant astrocytes. PLoS ONE. 2012;7:e47429. doi: 10.1371/journal.pone.0047429. PubMed DOI PMC

Reichert D, Scheinpflug J, Karbanová J, Freund D, Bornhäuser M, Corbeil D. Tunneling nanotubes mediate the transfer of stem cell marker CD133 between hematopoietic progenitor cells. Exp Hematol. 2016;44:1092–1112.e1092. doi: 10.1016/j.exphem.2016.07.006. PubMed DOI

Rappa G, Fargeas CA, Le TT, Corbeil D, Lorico A. Letter to the editor: an intriguing relationship between lipid droplets, cholesterol-binding protein CD133 and Wnt/β-catenin signaling pathway in carcinogenesis. Stem Cells. 2015;33:1366–1370. doi: 10.1002/stem.1953. PubMed DOI

Jang JW, Song Y, Kim SH, Kim J, Seo HR. Potential mechanisms of CD133 in cancer stem cells. Life Sci. 2017;184:25–29. doi: 10.1016/j.lfs.2017.07.008. PubMed DOI

Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629–635. doi: 10.1038/nature01148. PubMed DOI

Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4:446–456. doi: 10.1038/nrm1128. PubMed DOI

Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken) 2010;67:545–554. doi: 10.1002/cm.20472. PubMed DOI PMC

Guan G, Cannon RD, Coates DE, Mei L. Effect of the Rho-kinase/ROCK signaling pathway on cytoskeleton components. Genes (Basel) 2023;14:272. doi: 10.3390/genes14020272. PubMed DOI PMC

Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 1998;139:4991–4997. doi: 10.1210/endo.139.12.6390. PubMed DOI

Fantini J, Barrantes FJ. How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol. 2013;4:31. doi: 10.3389/fphys.2013.00031. PubMed DOI PMC

Fonseca A-V, Freund D, Bornhäuser M, Corbeil D. Polarization and migration of hematopoietic stem and progenitor cells rely on the RhoA/ROCK I pathway and an active reorganization of the microtubule network. J Biol Chem. 2010;285:31661–31671. doi: 10.1074/jbc.M110.145037. PubMed DOI PMC

Fonseca A-V, Corbeil D. The hematopoietic stem cell polarization and migration. Commun Integr Biol. 2011;4:201–204. doi: 10.4161/cib.4.2.14419. PubMed DOI PMC

Suzuki M. The Drosophila tweety family: molecular candidates for large-conductance Ca2+ activated Cl- channels. Exp Physiol. 2006;91:141–147. doi: 10.1113/expphysiol.2005.031773. PubMed DOI

Sukalskaia A, Straub MS, Deneka D, Sawicka M, Dutzler R. Cryo-EM structures of the TTYH family reveal a novel architecture for lipid interactions. Nat Commun. 2021;12:4893. doi: 10.1038/s41467-021-25106-4. PubMed DOI PMC

Li B, Hoel CM, Brohawn SG. Structures of tweety homolog proteins TTYH2 and TTYH3 reveal a Ca2+-dependent switch from intra- to intermembrane dimerization. Nat Commun. 2021;12:6913. doi: 10.1038/s41467-021-27283-8. PubMed DOI PMC

Melvin E, Kalaninová Z, Shlush E, Man P, Giladi M, Haitin Y. TTYH family members form tetrameric complexes at the cell membrane. Commun Biol. 2022;5:886. doi: 10.1038/s42003-022-03862-3. PubMed DOI PMC

Shimozato O, Waraya M, Nakashima K, Souda H, Takiguchi N, Yamamoto H, et al. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation. Oncogene. 2015;34:1949–1960. doi: 10.1038/onc.2014.141. PubMed DOI

Matsushita M, Mori Y, Uchiumi K, Ogata T, Nakamura M, Yoda H, et al. PTPRK suppresses progression and chemo-resistance of colon cancer cells via direct inhibition of pro-oncogenic CD133. FEBS Open Bio. 2019;9:935–946. doi: 10.1002/2211-5463.12636. PubMed DOI PMC

Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. 2006;7:833–846. doi: 10.1038/nrm2039. PubMed DOI

Xu Y, Tan L-J, Grachtchouk V, Voorhees JJ, Fisher GJ. Receptor-type protein-tyrosine phosphatase-κ regulates epidermal growth factor receptor function. J Biol Chem. 2005;280:42694–42700. doi: 10.1074/jbc.M507722200. PubMed DOI

Liang Z, Wu B, Ji Z, Liu W, Shi D, Chen X, et al. The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells. Cancer Lett. 2021;513:90–100. doi: 10.1016/j.canlet.2021.05.003. PubMed DOI

Takenobu H, Shimozato O, Nakamura T, Ochiai H, Yamaguchi Y, Ohira M, et al. CD133 suppresses neuroblastoma cell differentiation via signal pathway modification. Oncogene. 2011;30:97–105. doi: 10.1038/onc.2010.383. PubMed DOI

Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605–635. doi: 10.1016/j.cell.2017.07.029. PubMed DOI PMC

Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606–619. doi: 10.1038/nrg1879. PubMed DOI

Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol. 2010;11:329–341. doi: 10.1038/nrm2882. PubMed DOI

Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev. 2008;4:203–210. doi: 10.1007/s12015-008-9021-5. PubMed DOI

Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169:381–405. doi: 10.1016/j.cell.2017.04.001. PubMed DOI PMC

Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489–501. doi: 10.1038/nrc839. PubMed DOI

Getz G, Gabriel SB, Cibulskis K, Lander E, Sivachenko A, Sougnez C, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67–73. doi: 10.1038/nature12113. PubMed DOI PMC

Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–209. doi: 10.1038/nature13480. PubMed DOI PMC

Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176–187. doi: 10.1016/j.cell.2014.08.016. PubMed DOI PMC

Lawrence MS, Sougnez C, Lichtenstein L, Cibulskisl K, Lander E, Gabriel SB, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–582. doi: 10.1038/nature14129. PubMed DOI PMC

Liu Y, Easton J, Shao Y, Maciaszek J, Wang ZM, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211–1218. doi: 10.1038/ng.3909. PubMed DOI PMC

Manoranjan B, Chokshi C, Venugopal C, Subapanditha M, Savage N, Tatari N, et al. A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells. Oncogene. 2020;39:1590–1599. doi: 10.1038/s41388-019-1086-x. PubMed DOI

Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785–789. doi: 10.1038/378785a0. PubMed DOI

Shibahara I, Sonoda Y, Saito R, Kanamori M, Yamashita Y, Kumabe T, et al. The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence. Neuro Oncol. 2013;15:1151–1159. doi: 10.1093/neuonc/not066. PubMed DOI PMC

Wang Z, Liu W, Wang C, Li Y, Ai Z. Acetylcholine promotes the self-renewal and immune escape of CD133+ thyroid cancer cells through activation of CD133-Akt pathway. Cancer Lett. 2020;471:116–124. doi: 10.1016/j.canlet.2019.12.009. PubMed DOI

Jamal SME, Alamodi A, Wahl RU, Grada Z, Shareef MA, Hassan S-Y, et al. Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathways. Oncogene. 2020;39:5468–5478. doi: 10.1038/s41388-020-1373-6. PubMed DOI

Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18:128–134. doi: 10.1038/nrc.2017.118. PubMed DOI

Olea-Flores M, Zuñiga-Eulogio M, Tacuba-Saavedra A, Bueno-Salgado M, Sánchez-Carvajal A, Vargas-Santiago Y, et al. Leptin promotes expression of EMT-related transcription factors and invasion in a Src and FAK-dependent pathway in MCF10A mammary epithelial cells. Cells. 2019;8:1133. doi: 10.3390/cells8101133. PubMed DOI PMC

Tian Q, Yuan P, Quan C, Li M, Xiao J, Zhang L, et al. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer. Oncogene. 2020;39:3980–3996. doi: 10.1038/s41388-020-1262-z. PubMed DOI PMC

Patel A, Sabbineni H, Clarke A, Somanath PR. Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis. Life Sci. 2016;157:52–61. doi: 10.1016/j.lfs.2016.05.036. PubMed DOI PMC

Tai Y-L, Chen L-C, Shen T-L. Emerging roles of focal adhesion kinase in cancer. Biomed Res Int. 2015;2015:690690. doi: 10.1155/2015/690690. PubMed DOI PMC

Lee BY, Timpson P, Horvath LG, Daly RJ. FAK signaling in human cancer as a target for therapeutics. Pharmacol Ther. 2015;146:132–149. doi: 10.1016/j.pharmthera.2014.10.001. PubMed DOI

Tai Y-L, Chu P-Y, Lai IR, Wang M-Y, Tseng H-Y, Guan J-L, et al. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer. Sci Rep. 2015;5:16408. doi: 10.1038/srep16408. PubMed DOI PMC

Liu C, Li Y, Xing Y, Cao B, Yang F, Yang T, et al. The interaction between cancer stem cell marker CD133 and Src protein promotes focal adhesion kinase (FAK) phosphorylation and cell migration. J Biol Chem. 2016;291:15540–15550. doi: 10.1074/jbc.M115.712976. PubMed DOI PMC

Nusse R, Brown A, Papkoff J, Scambler P, Shackleford G, McMahon A, et al. A new nomenclature for int-1 and related genes: the Wnt gene family. Cell. 1991;64:231. doi: 10.1016/0092-8674(91)90633-A. PubMed DOI

Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781–810. doi: 10.1146/annurev.cellbio.20.010403.113126. PubMed DOI

Nusse R, Clevers H. Wnt/β-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985–999. doi: 10.1016/j.cell.2017.05.016. PubMed DOI

Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–398. doi: 10.1038/nrc2389. PubMed DOI

Sawa H. Control of cell polarity and asymmetric division in C. elegans. Curr Top Dev Biol. 2012;101:55–76. doi: 10.1016/B978-0-12-394592-1.00003-X. PubMed DOI

Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell. 2001;105:533–545. doi: 10.1016/S0092-8674(01)00336-1. PubMed DOI

Gay DL, Yang CC, Plikus MV, Ito M, Rivera C, Treffeisen E, et al. CD133 expression correlates with membrane beta-catenin and E-cadherin loss from human hair follicle placodes during morphogenesis. J Invest Dermatol. 2015;135:45–55. doi: 10.1038/jid.2014.292. PubMed DOI PMC

Brossa A, Papadimitriou E, Collino F, Incarnato D, Oliviero S, Camussi G, et al. Role of CD133 molecule in Wnt response and renal repair. Stem Cells Transl Med. 2018;7:283–294. doi: 10.1002/sctm.17-0158. PubMed DOI PMC

Tremblay JR, Lopez K, Ku HT. A GLIS3–CD133–WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids. J Biol Chem. 2019;294:16634–16649. doi: 10.1074/jbc.RA118.002818. PubMed DOI PMC

Mak AB, Nixon AML, Kittanakom S, Stewart JM, Chen GI, Curak J, et al. Regulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiation. Cell Rep. 2012;2:951–963. doi: 10.1016/j.celrep.2012.09.016. PubMed DOI PMC

Rappa G, Fodstad O, Lorico A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells. 2008;26:3008–3017. doi: 10.1634/stemcells.2008-0601. PubMed DOI PMC

Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455–458. doi: 10.1038/417455a. PubMed DOI

Li Y, Zhang X, Polakiewicz RD, Yao TP, Comb MJ. HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem. 2008;283:12686–12690. doi: 10.1074/jbc.C700185200. PubMed DOI PMC

Miyake Y, Keusch JJ, Wang LL, Saito M, Hess D, Wang XN, et al. Structural insights into HDAC6 tubulin deacetylation and its selective inhibition. Nat Chem Biol. 2016;12:748–754. doi: 10.1038/nchembio.2140. PubMed DOI

Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003;115:727–738. doi: 10.1016/S0092-8674(03)00939-5. PubMed DOI

Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A. 2003;100:4389–4394. doi: 10.1073/pnas.0430973100. PubMed DOI PMC

Deribe YL, Wild P, Chandrashaker A, Curak J, Schmidt MHH, Kalaidzidis Y, et al. Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6. Sci Signal. 2009;2:ra84. PubMed

David CJ, Massagué J. Contextual determinants of TGFβ action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19:419–435. doi: 10.1038/s41580-018-0007-0. PubMed DOI PMC

Lee J, Shin JE, Lee B, Kim H, Jeon Y, Ahn SH, et al. The stem cell marker Prom1 promotes axon regeneration by down-regulating cholesterol synthesis via Smad signaling. Proc Natl Acad Sci U S A. 2020;117:15955–15966. doi: 10.1073/pnas.1920829117. PubMed DOI PMC

Lee H, Yu D-M, Bahn M-S, Kwon Y-J, Um MJ, Yoon SY, et al. Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7. Exp Mol Med. 2022;54:1277–1289. doi: 10.1038/s12276-022-00831-y. PubMed DOI PMC

Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 1997;389:631–635. doi: 10.1038/39369. PubMed DOI

Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997;89:1165–1173. doi: 10.1016/S0092-8674(00)80303-7. PubMed DOI

Fenlon M, Short C, Xu J, Malkoff N, Mahdi E, Hough M, et al. Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury. Physiol Rep. 2020;8:e14508. doi: 10.14814/phy2.14508. PubMed DOI PMC

Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016;64:1403–1415. doi: 10.1016/j.jhep.2016.02.004. PubMed DOI

Bahn M-S, Yu D-M, Lee M, Jo S-J, Lee J-W, Kim H-C, et al. Central role of Prominin-1 in lipid rafts during liver regeneration. Nat Commun. 2022;13:6219. doi: 10.1038/s41467-022-33969-4. PubMed DOI PMC

Deming PB, Campbell SL, Stone JB, Rivard RL, Mercier AL, Howe AK. Anchoring of protein kinase A by ERM (Ezrin-Radixin-Moesin) proteins is required for proper netrin signaling through DCC (deleted in colorectal cancer) J Biol Chem. 2015;290:5783–5796. doi: 10.1074/jbc.M114.628644. PubMed DOI PMC

Dema A, Perets E, Schulz MS, Deák VA, Klussmann E. Pharmacological targeting of AKAP-directed compartmentalized cAMP signalling. Cell Signal. 2015;27:2474–2487. doi: 10.1016/j.cellsig.2015.09.008. PubMed DOI

Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607–632. doi: 10.1038/s41580-020-0255-7. PubMed DOI

Ding Q, Miyazaki Y, Tsukasa K, Matsubara S, Yoshimitsu M, Takao S. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Mol Cancer. 2014;13:15. doi: 10.1186/1476-4598-13-15. PubMed DOI PMC

Xin B, He X, Wang J, Cai J, Wei W, Zhang T, et al. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer. Pancreatology. 2016;16:1005–1014. doi: 10.1016/j.pan.2016.09.005. PubMed DOI

Zhang L, Zhang L, Li H, Ge C, Zhao F, Tian H, et al. CXCL3 contributes to CD133+ CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation. Sci Rep. 2016;6:27426. doi: 10.1038/srep27426. PubMed DOI PMC

Vora P, Venugopal C, Salim SK, Tatari N, Bakhshinyan D, Singh M, et al. The rational development of CD133-targeting immunotherapies for glioblastoma. Cell Stem Cell. 2020;26:832–844.e836. doi: 10.1016/j.stem.2020.04.008. PubMed DOI